ID: ALA4289564

Max Phase: Preclinical

Molecular Formula: C15H11NO4S

Molecular Weight: 301.32

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C1/C(=C/c2cccc(O)c2)NS(=O)(=O)c2ccccc21

Standard InChI:  InChI=1S/C15H11NO4S/c17-11-5-3-4-10(8-11)9-13-15(18)12-6-1-2-7-14(12)21(19,20)16-13/h1-9,16-17H/b13-9-

Standard InChI Key:  SOUJRYLSJKODRT-LCYFTJDESA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 301.32

Molecular Weight (Monoisotopic): 301.0409

AlogP: 1.91

#Rotatable Bonds: 1

Polar Surface Area: 83.47

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 7.40

CX Basic pKa:

CX LogP: 1.89

CX LogD: 1.63

Aromatic Rings: 2

Heavy Atoms: 21

QED Weighted: 0.79

Np Likeness Score: -0.29

References

1. Ashraf A, Ejaz SA, Rahman SU, Siddiqui WA, Arshad MN, Lecka J, Sévigny J, Zayed MEM, Asiri AM, Iqbal J, Hartinger CG, Hanif M..  (2018)  Hybrid compounds from chalcone and 1,2-benzothiazine pharmacophores as selective inhibitors of alkaline phosphatase isozymes.,  159  [PMID:30296687] [10.1016/j.ejmech.2018.09.063]

Source

Source(1):

• Scientific Literature